Jon Nugent Communications advises Boards and management teams at the decision points that determine a company's value: financings, M&A, clinical and regulatory milestones, restructurings, and the strategic choices around them.


Our counsel is grounded in three decades inside public biotechs and at the advisory table, across North America, Europe, the Middle East, and Asia.


Experienced judgment, applied where the consequences are greatest, and sustained well beyond the headline event.

THE FIRM


Built on three decades at the intersection of science and capital. 

OUR PRACTICE

CAPITAL MARKETS COUNSEL

Valuation positioning, milestone sequencing, and the strategic decisions that shape how the market sees a company

BOARD AND EXECUTIVE ADVISORY

Trusted counsel through the decisions that define a company's path.

FINANCING STRATEGY

Capital structure, financing pathway, and syndicate decisions for public and private companies at every stage of growth.

INVESTOR RELATIONS

Shareholder composition strategy, institutional positioning, and the disclosure architecture that sustains long-term investor support.

M&A AND STRATEGIC TRANSACTIONS

Stakeholder strategy, deal narrative, and Board-level counsel through transactions that redefine the enterprise.

CLINICAL AND REGULATORY MILESTONES

Market preparation, disclosure judgment, and the narrative discipline that turns data into durable value.

JON NUGENT COMMUNICATIONS

info@jonnugent.com      205-566-3026


MILESTONES

4

CONTINENTS

30+

YEARS

Senior counsel for life sciences leadership.


Capital markets, investor relations, and strategic communications for biotechnology Boards and C-suites worldwide.

Jon

Nugent

Communications

EXPERIENCE

We have developed successful strategies for more than 300 comapnies.

Selected past engagements include